How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/prevention-of-rsv-lower-respiratory-tract-disease-in-infants-and-children-at-high-risk-of-rsv-disease.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target
RSVpreF MDV	rsvpref-mdv	Pfizer Inc.	Monoclonal antibody	RSV F protein
RSVpreF	rsvpref	Pfizer	Monoclonal antibody	RSV F protein
RSVpreF 120 µg	rsvpref-120-g	Pfizer	Recombinant subunit vaccine	Prefusion form of the RSV F protein

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 2 drugs in Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease
Pfizer Inc. · 1 drug in Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease:

Cite this brief

Drug Landscape (2026). Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-rsv-lower-respiratory-tract-disease-in-infants-and-children-at-high-risk-of-rsv-disease. Accessed 2026-06-10.

Prevention of RSV lower respiratory tract disease in infants and children at high risk of RSV disease full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing